GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SciVision Biotech 1786.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

51.10

+8.61%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 886.6m

FY2016FY2025

Net income

TWD 162.3m

FY2016FY2025

Free cash flow

TWD 22.5m

FY2016FY2025

Shareholders' equity

TWD 1.98bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 886.6mTWD 883.3mTWD 713.0mTWD 557.3mTWD 505.5mTWD 466.9mTWD 437.9mTWD 329.6mTWD 258.4mTWD 228.3m
Gross profitTWD 638.4mTWD 655.7mTWD 512.5mTWD 371.9mTWD 341.8mTWD 343.3mTWD 305.5mTWD 216.9mTWD 152.8mTWD 127.2m
Research and developmentTWD 93.2mTWD 60.7mTWD 53.4mTWD 52.5mTWD 65.9mTWD 59.8mTWD 43.3mTWD 48.0mTWD 39.3mTWD 30.5m
Operating incomeTWD 189.9mTWD 248.1mTWD 199.6mTWD 176.2mTWD 124.2mTWD 161.9mTWD 140.7mTWD 83.3mTWD 26.9m−TWD 26.0m
Net incomeTWD 162.3mTWD 242.3mTWD 177.9mTWD 141.7mTWD 101.7mTWD 128.0mTWD 120.7mTWD 86.9mTWD 17.1m−TWD 26.3m
Diluted earnings per share2.223.112.122.151.431.941.811.430.37-0.44

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 2.67bnTWD 2.35bnTWD 2.16bnTWD 2.10bnTWD 2.26bnTWD 1.89bnTWD 1.86bnTWD 1.70bnTWD 1.56bnTWD 1.36bn
Cash and short-term investmentsTWD 1.05bnTWD 871.4mTWD 804.1mTWD 673.9mTWD 695.8mTWD 413.3mTWD 428.3mTWD 385.2mTWD 346.5mTWD 474.2m
Total liabilitiesTWD 689.3mTWD 457.4mTWD 533.7mTWD 587.3mTWD 812.1mTWD 486.5mTWD 501.1mTWD 617.7mTWD 648.7mTWD 462.9m
DebtTWD 485.1mTWD 224.2mTWD 347.9mTWD 412.0mTWD 633.1mTWD 321.1mTWD 311.4mTWD 363.6mTWD 498.8mTWD 310.7m
Shareholders' equityTWD 1.98bnTWD 1.90bnTWD 1.63bnTWD 1.51bnTWD 1.45bnTWD 1.40bnTWD 1.36bnTWD 1.08bnTWD 914.5mTWD 894.2m
Shares outstanding73m78m84m66m71m66m67m61m47m60m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 124.0mTWD 269.9mTWD 272.0mTWD 178.2mTWD 98.5mTWD 126.5mTWD 204.4mTWD 111.7mTWD 16.0mTWD 38.3m
Capital spending−TWD 101.5m−TWD 34.9m−TWD 14.8m−TWD 15.0m−TWD 25.8m−TWD 66.8m−TWD 202.0m−TWD 95.3m−TWD 324.3m−TWD 230.3m
Free cash flowTWD 22.5mTWD 235.0mTWD 257.2mTWD 163.2mTWD 72.7mTWD 59.6mTWD 2.4mTWD 16.4m−TWD 308.3m−TWD 192.0m
Dividends paid−TWD 233.9m−TWD 169.3m−TWD 133.3m−TWD 93.8m−TWD 58.6m−TWD 79.3m−TWD 93.0m−TWD 10.3m−TWD 10.3m−TWD 25.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 211.0mTWD 205.3mTWD 251.4mTWD 221.4mTWD 209.5mTWD 204.3mTWD 255.2mTWD 222.2m
Gross profitTWD 133.2mTWD 139.6mTWD 189.4mTWD 148.0mTWD 152.8mTWD 142.2mTWD 189.5mTWD 160.4m
Operating incomeTWD 28.7mTWD 21.3mTWD 49.9mTWD 46.4mTWD 33.0mTWD 60.6mTWD 60.2mTWD 74.7m
Net incomeTWD 34.6mTWD 22.0mTWD 63.2mTWD 58.3m−TWD 16.0mTWD 56.9mTWD 65.6mTWD 57.2m
Diluted earnings per share0.470.300.860.80-0.220.780.840.73
Cash from operationsTWD 67.0mTWD 48.0m−TWD 13.0mTWD 15.0mTWD 6.0mTWD 115.0mTWD 100.0mTWD 42.0m
Capital spending−TWD 4.0m−TWD 9.0m−TWD 19.0m−TWD 32.0m−TWD 29.0m−TWD 20.0m−TWD 9.0m−TWD 15.0m
Free cash flowTWD 63.0mTWD 39.0m−TWD 32.0m−TWD 17.0m−TWD 23.0mTWD 95.0mTWD 91.0mTWD 27.0m
Total assetsTWD 2.51bnTWD 2.75bnTWD 2.67bnTWD 2.61bnTWD 2.19bnTWD 2.44bnTWD 2.35bnTWD 2.15bn
Cash and short-term investmentsTWD 905.7mTWD 1.09bnTWD 1.05bnTWD 1.08bnTWD 703.5mTWD 965.8mTWD 871.4mTWD 782.4m
DebtTWD 10.3mTWD 386.3mTWD 383.8mTWD 381.0mTWD 131.6mTWD 126.5mTWD 139.5mTWD 138.2m
Shareholders' equityTWD 1.79bnTWD 1.86bnTWD 1.98bnTWD 1.92bnTWD 1.72bnTWD 1.74bnTWD 1.90bnTWD 1.82bn

Financial ratios

Data as of 16 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin72.0%74.2%71.9%66.7%67.6%73.5%
Operating margin21.4%33.7%30.6%31.6%24.6%34.7%
Net margin18.3%27.4%25.0%25.4%20.1%27.4%
Return on equity8.2%12.8%10.9%9.4%7.0%9.1%
Return on assets6.1%10.3%8.2%6.8%4.5%6.8%
Free cash flow yield7.5%9.5%8.3%7.1%4.3%7.2%
Revenue growth0.4%23.9%27.9%10.2%8.3%6.6%
Earnings growth-33.0%36.2%25.5%39.3%-20.5%6.0%
Current ratio8.17x3.46x6.92x6.88x2.17x4.55x
Debt to equity0.19x0.07x0.20x0.26x0.42x0.21x
Equity ratio74.2%80.6%75.3%72.0%64.1%74.3%
Interest coverage24.35x52.40x26.55x27.29x15.40x21.68x
R&D as a share of sales10.5%6.9%7.5%9.4%13.0%12.8%
Buybacks as a share of market value6.2%7.2%-27.4%7.0%-7.7%0.9%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue16.7%13.7%12.8%
Operating income2.5%3.2%15.0%
Net income4.6%4.9%11.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin73.1%71.7%71.4%69.1%
Operating margin24.7%26.8%27.4%24.8%
Net margin22.9%23.8%23.8%21.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings32.733.536.725.234.629.334.739.384.0-110.3
Price to sales6.09.29.26.47.08.09.610.35.612.7

Dividends and splits

Per share, in the currency the company pays

Paid for 8 years. Last went ex-dividend on 29 Apr 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year1.9093.242.5331.981.4180.961.1970.75
  • 1.085-for-1 split · 4 Oct 2021
  • 21-for-20 split · 2 Sept 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.